Publications

Included here is a list of publications from OCG programs. All published data are available to the research community through the program-specific data matrices.

* denotes publications from the CTD² initiative that are results of intra-Network collaborations

CTD²

October 05, 2020

Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors

The Journal of Clinical Investigation

CTD²

October 01, 2020

BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancer

EBioMedicine

CTD²

September 28, 2020

Development of a DNA Methylation-Based Diagnostic Signature to Distinguish Benign Oncocytoma From Renal Cell Carcinoma

JCO Precision Oncology

CTD²

September 03, 2020

Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing

Cell

CTD²

September 01, 2020

High expression of MKK3 is associated with worse clinical outcomes in African American breast cancer patients

Journal of Translational Medicine

CTD²

September 01, 2020

Plasticity of ether lipids promotes ferroptosis susceptibility and evasion

Nature

CTD²

August 20, 2020

The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies.

Nat Immunol.

CGCI

August 03, 2020

Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade-specific epigenome and transcriptome landscapes

Nature genetics

HTMCP scientists reveal the influence of HPV clades on molecular characteristics of HIV+ and HIV- cervical tumors from Ugandan patients. The study provides insights into the role of HIV infection, and how different HPV clades lead to specific molecular changes that could affect patient prognosis.

CTD²

August 01, 2020